The group’s principle activities include research, developing and manufacturing biotechnology products. The group’s services include high throughput robotic screening, gene overexpression and optimization, strain improvement and process development. The group operates from United States.
Executive Information
Name
Title
Email
Mark Emalfarb
Chmn., CEO, Pres.
N/A
Richard Learner
Chmn., Dyadic Scientific Advisory Board
N/A
Glenn Nedwin
Dir., Pres., Chief Scientific Officer - Biosciences Business
